Skip to main content
Clinical Trials/EUCTR2018-003675-35-SE
EUCTR2018-003675-35-SEActive, not recruitingPhase 1

Efficacy of Very Early Medical Abortion – a randomized controlled non-inferiority trial - VEMA – Very Early Medical Abortion Trial

Karolinska Institutet0 sites1,500 target enrollmentStarted: September 24, 2018Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
1,500

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • 1.Women 18 years of age or above eligible for medical abortion
  • 2.No signs of pathological pregnancy
  • 3.No confirmed IUP
  • 4.Willing and able to participate after the study has been explained
  • 5.Signed informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1500
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • 1.Allergy towards mifepristone or misoprostol
  • 2.A medical condition or disease that requires special treatment, care or precaution (e.g. corticosteroid or anticoagulant therapy) in conjunction with abortion

Investigators

Similar Trials